Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists.

Cian O'Mahony Kieran DaltonLeon O'HaganKevin Daniel MurphyClare KinahanEmma CoyleLaura J Sahm Stephen Byrne Ciara Kirke

Published in: International journal of clinical pharmacy (2024)

Person-centred medicines reviews by general practice pharmacists for patients at high risk of medicines-related harm result in substantial cost savings. Wider investment in general practice pharmacists will be beneficial to minimise both patient harm and healthcare system expenditure.

Keyphrases

general practice
primary care
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
randomized controlled trial
systematic review
life cycle